Quest Partners LLC Myriad Genetics Inc Transaction History
Quest Partners LLC
- $575 Billion
- Q1 2024
A detailed history of Quest Partners LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Quest Partners LLC holds 49 shares of MYGN stock, worth $1,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49Holding current value
$1,372% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MYGN
# of Institutions
195Shares Held
94.2MCall Options Held
280KPut Options Held
14.3K-
Black Rock Inc. New York, NY14.9MShares$417 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$281 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.06MShares$226 Million0.03% of portfolio
-
Camber Capital Management LP Boston, MA7.64MShares$214 Million3.99% of portfolio
-
State Street Corp Boston, MA5.4MShares$151 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2.26B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...